Avet Pharmaceuticals, Inc.
Avet Pharmaceuticals, Inc. appears in FDA public data with 4 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1104-2020, Class II) was initiated on March 26, 2020.
Summary
- Total Recalls
- 4 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1104-2020 | Class II | Losartan Potassium Tablets USP 100 mg, supplied in a) 30 count (NDC 23155-646-03, b) 90 count (NDC 2 | March 26, 2020 |
| D-1103-2020 | Class II | Losartan Potassium Tablets USP 50 mg, a) 30 count (NDC 23155-645-03), b) 90 count (NDC 23155-645-09) | March 26, 2020 |
| D-1255-2020 | Class I | Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharm | March 23, 2020 |
| D-1254-2020 | Class I | Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharm | March 23, 2020 |